UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

: Sobril-10mg-Tablet-SE-IS-ING07 - JSON Representation

Raw json | Download


{
  "resourceType" : "Ingredient",
  "id" : "Sobril-10mg-Tablet-SE-IS-ING07",
  "meta" : {
    "profile" : [
      🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Ingredient Sobril-10mg-Tablet-SE-IS-ING07</b></p><a name=\"Sobril-10mg-Tablet-SE-IS-ING07\"> </a><a name=\"hcSobril-10mg-Tablet-SE-IS-ING07\"> </a><a name=\"hcSobril-10mg-Tablet-SE-IS-ING07-en-US\"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href=\"MedicinalProductDefinition-Sobril-10mg-Tablet-SE-IS-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001390-00008880,http://ema.europa.eu/fhir/eurdId#2234; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Sobril påverkar de vid ångestsyndrom vanliga symtomen: ängslan, ångest, rastlöshet och  sömnsvårigheter. Vid depressioner med inslag av nyss nämnda symtom kan Sobril användas  tillsammans med sedvanliga antidepressiva farmaka.  Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom som ångest, spänning och  excitation i samband med alkoholmissbruk.; legalStatusOfSupply = Medicinal product subject to special medical prescription; classification = N05BA04</a></li><li><a href=\"ManufacturedItemDefinition-Sobril-10mg-Tablet-SE-IS-MID.html\">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></li><li><a href=\"AdministrableProductDefinition-Sobril-10mg-Tablet-SE-IS-APD.html\">AdministrableProductDefinition: status = active; administrableDoseForm = Tablet</a></li></ul><p><b>role</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072082}\">Excipient</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000135889}\">Sodium laurilsulfate</span></td></tr></table></blockquote></div>"
  },
  "status" : "active",
  "for" : [
    {
      🔗 "reference" : "MedicinalProductDefinition/Sobril-10mg-Tablet-SE-IS-MPD"
    },
    {
      🔗 "reference" : "ManufacturedItemDefinition/Sobril-10mg-Tablet-SE-IS-MID"
    },
    {
      🔗 "reference" : "AdministrableProductDefinition/Sobril-10mg-Tablet-SE-IS-APD"
    }
  ],
  "role" : {
    "coding" : [
      {
        "system" : "https://spor.ema.europa.eu/v1/lists/100000072050",
        "code" : "100000072082",
        "display" : "Excipient"
      }
    ]
  },
  "substance" : {
    "code" : {
      "concept" : {
        "coding" : [
          {
            "system" : "https://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
            "code" : "100000135889",
            "display" : "Sodium laurilsulfate"
          }
        ]
      }
    }
  }
}